-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MToTyqcyYgoKQwLACwYbeeLD2+KkRZplSlp3M7fjZPlNIC+KaV3LCzVFKZDCEU58 rB/VA8dIC0AmXYgeFcAJ+w== 0001340362-06-000009.txt : 20060223 0001340362-06-000009.hdr.sgml : 20060223 20060223192114 ACCESSION NUMBER: 0001340362-06-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060215 FILED AS OF DATE: 20060223 DATE AS OF CHANGE: 20060223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reith John H CENTRAL INDEX KEY: 0001311253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09957 FILM NUMBER: 06640742 BUSINESS ADDRESS: BUSINESS PHONE: 310-725-7039 MAIL ADDRESS: STREET 1: DIAGNOSTIC PRODUCTS CORPORATION STREET 2: 5210 PACIFIC CONCOURSE DRIVE CITY: LOS ANGELES STATE: CA ZIP: 90045 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DIAGNOSTIC PRODUCTS CORP CENTRAL INDEX KEY: 0000702259 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 952802182 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5210 PACIFIC CONCOURSE DRIVE CITY: LOS ANGELES STATE: CA ZIP: 90045 BUSINESS PHONE: 3106458200 MAIL ADDRESS: STREET 1: 5210 PACIFIC CONCOURSE DRIVE CITY: LOS ANGELES STATE: CA ZIP: 90045 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2006-02-15 0 0000702259 DIAGNOSTIC PRODUCTS CORP DP 0001311253 Reith John H DIAGNOSTIC PRODUCTS CORPORATION 5210 PACIFIC CONCOURSE DRIVE LOS ANGELES CA 90045 1 0 0 0 Stock Option Right to Buy 48.73 2006-02-15 4 A 0 5000 0 A 2007-02-15 2013-02-15 Common Stock 5000 5000 D Vests 1000 shares on the Anniversary Date 2007, 2008, 2009, 2010 and 2011. Exhibit List: Exhibit 24 - Confirming Statement James L. Brill, Authorized Signer 2006-02-23 EX-24 2 confirmingstatement.txt CONFIRMING STATEMENT CONFIRMING STATEMENT This Statement confirms that the undersigned has authorized and designated James Brill or Annick Winkler to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the United States Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of Diagnostic Products Corporation. The authority of James Brill or Annick Winkler under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of Diagnostic Products Corporation, unless revoked earlier in writing. The undersigned acknowledges that James Brill or Annick Winkler is not assuming, nor is Diagnostic Products Corporation assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. Dated: November 18, 2004 John Reith Signature John Reith Print Name -----END PRIVACY-ENHANCED MESSAGE-----